儿童淋巴瘤的监测影像学
本文综述了近期关于儿童霍奇金淋巴瘤及多种非霍奇金淋巴瘤亚型治疗后监测影像的研究,指出常规治疗外监测影像的作用受到质疑,并提出一种基于风险适应和疗效反应的新型监测影像策略,以确定哪些儿童最能从治疗外影像监测中获益。
要点
- 儿童霍奇金淋巴瘤及多种非霍奇金淋巴瘤亚型当前治疗的总体生存率在许多情况下超过90%。
- 对影像学检查费用、电离辐射暴露及潜在假阳性结果的担忧使常规治疗外监测影像的作用受到质疑。
- 作者提出一种基于风险适应和疗效反应的新型监测影像策略,以确定哪些儿童最能从治疗外影像监测中获益。
核心结论
- 在完成治疗后多数结局优良的儿童淋巴瘤患者中,存在大幅减少治疗外影像评估次数的机会。
- 作者提出一种基于风险适应和疗效反应的新型监测影像策略,以确定哪些儿童最能从治疗外影像监测中获益。
研究设计与样本
- 综述总结了近期关于霍奇金淋巴瘤和非霍奇金淋巴瘤的研究证据。
- 原文未报告检索范围与纳入文献数量。
临床应用与阅片要点
- 作者提出一种基于风险适应和疗效反应的新型监测影像策略,以确定哪些儿童最能从治疗外影像监测中获益。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
Current therapies used in treating children with Hodgkin lymphoma and many histological subtypes of non-Hodgkin lymphoma have resulted in overall survival rates exceeding 90% in many instances. With increasing concerns related to the cost of radiologic imaging, exposure to ionizing radiation, and potential false-positive results, the role of routine off-therapy surveillance imaging has been called into question. Although radiologic imaging plays an important role in diagnosing and assessing treatment response, in these children - the majority of whom have an excellent outcome following completion of therapy - there is an opportunity to dramatically reduce the number of off-therapy imaging evaluations. This review summarizes several recent studies in both Hodgkin and non-Hodgkin lymphoma providing evidence to support these efforts. In addition, we propose a surveillance imaging strategy that uses a novel risk-adapted and response-based approach to determine which children would most benefit from off-therapy imaging surveillance.
引用
- Voss SD, Cairo MS. Surveillance imaging in pediatric lymphoma. Pediatr Radiol. 2019. PMID: 31620855. doi:10.1007/s00247-019-04511-4
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。